Lucinda Billingham

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Randomized Controlled Trial

Acute Lymphoblastic Leukemia

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Tobias Menne, Daniel Slade, Joshua S Savage, Sarah Johnson, Julie Irving, Pamela Kearns, Ruth Plummer, Geoff Shenton, Gareth J Veal, Britta Vormoor, Josef Vormoor, Lucinda Billingham
Selumetinib in combination with dexamethasone for the treatment of relapsed/refractory RAS-pathway mutated paediatric and adult acute lymphoblastic leukaemia (SeluDex): study protocol for an international, parallel-group, dose-finding with expansion phase I/II trial. BMJ open 12 (3) (2022)
Colin Watts, Joshua S Savage, Amit Patel, Rhys Mant, Victoria Wykes, Ute Pohl, Helen Bulbeck, John Apps, Rowena Sharpe, Gerard Thompson, Adam D Waldman, Olaf Ansorge, Lucinda Billingham, null null
Protocol for the Tessa Jowell BRAIN MATRIX Platform Study. BMJ open 12 (9) (2022)
Jennifer Pascoe, Aimee Jackson, Charlotte Gaskell, Claire Gaunt, Joyce Thompson, Lucinda Billingham, Neil Steven
Beta-hydroxy beta-methylbutyrate/arginine/glutamine (HMB/Arg/Gln) supplementation to improve the management of cachexia in patients with advanced lung cancer: an open-label, multicentre, randomised, controlled phase II trial (NOURISH). BMC cancer 21 (1) (2021)